STVNStevanato Group S.p.A.
Is it safe?
Mostly sound, with a caveat: comfortable debt (AA), but big price swings.
Insiders were net sellers (-$460K, 90 days to Oct 8, 2026), selling is often routine.
Rock-solid balance sheet, low leverage. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -62% · now 30% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can STVN take a bad year?
Stevanato Group S.p.A. carries $314M of net debt at 1.09× EBITDA: a load its earnings can carry.
Net debt · as at FY2025 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.09×
Net debt / EBITDA · 1.29× a year ago · the load is coming down
- Interest cover
- 35.4×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 49%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtFY2025
- $455M
- Cash and short-term investments
- $141M
- Net debt
- $314M
- EBITDA, trailing twelve months
- $287M
- Operating profit, trailing twelve months
- $199M
- Debt / equity
- 0.31×
- Total debt / EBITDA
- 1.58×
- Annualised volatilitytwo years of daily moves
- 49%
- Worst drawdown on file
- −62%
- Below its 52-week high
- 30%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #4 of 21 by RyuScore